0001755010-25-000003.txt : 20251110 0001755010-25-000003.hdr.sgml : 20251110 20251110155237 ACCESSION NUMBER: 0001755010-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251110 DATE AS OF CHANGE: 20251110 EFFECTIVENESS DATE: 20251110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EPALEX Corp CENTRAL INDEX KEY: 0001755010 ORGANIZATION NAME: EIN: 273424771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563583 FILM NUMBER: 251465959 BUSINESS ADDRESS: STREET 1: 1049 EL MONTE AVENUE, SUITE C 585 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 BUSINESS PHONE: 659-946-3366 X700 MAIL ADDRESS: STREET 1: 1049 EL MONTE AVENUE, SUITE C 585 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 D 1 primary_doc.xml X0708 D LIVE 0001755010 EPALEX Corp 1049 EL MONTE AVENUE, SUITE C 585 MOUNTAIN VIEW CA CALIFORNIA 94040 659-946-3366 X700 DELAWARE None None Corporation true Brendan Magrab c/o Epalex Corporation 1049 El Monte Avenue, Suite C585 Mountain View CA CALIFORNIA 94040 Executive Officer Director Didric Cedarholm c/o Epalex Corporation 1049 El Monte Avenue, Suite C585 Mountain View CA CALIFORNIA 94040 Director Randall Murphy c/o Epalex Corporation 1049 El Monte Avenue, Suite C585 Mountain View CA CALIFORNIA 94040 Director Michael Rogawski c/o Epalex Corporation 1049 El Monte Avenue, Suite C585 Mountain View CA CALIFORNIA 94040 Director Jon Saxe c/o Epalex Corporation 1049 El Monte Avenue, Suite C585 Mountain View CA CALIFORNIA 94040 Director Pharmaceuticals Decline to Disclose 06b false 2025-10-31 false true false 0 3199991 1200000 1999991 false 1 0 0 0 The proceeds are available to fund general working capital requirements; as of the date of this filing, no detailed operating budget has been adopted; and no proceeds have been or are proposed to be used for payments of finders fees or other compensation. false EPALEX Corp /s/ Brendan Magrab Brendan Magrab Chief Executive Officer 2025-11-09